← Open Payments lookup

TZU-YI WANG: Open Payments

NPI 1346773819 · MODESTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,111 in 17 payments from 8 companies in 2025. Trend: 2023 $686 · 2024 $1,248 · 2025 $1,111

Food & beverage: $1,111
CompanyPaymentsAmount
Ascendis Pharma Endocrinology Inc3$265
Novo Nordisk Inc4$237
Madrigal Pharmaceuticals3$202
Corcept Therapeutics1$118
Lilly USA, LLC2$107
BETA BIONICS, INC.1$89
AstraZeneca Pharmaceuticals LP1$55
Dexcom, Inc.2$39

Products named: Yorvipath, REZDIFFRA, Korlym, iLet Bionic Pancreas, Ozempic, ZEPBOUND, MOUNJARO, Dexcom G6 Transmitter.

Industry payments across CA — which companies pay providers there.